CCM

Cribstone Capital Management Portfolio holdings

AUM $172M
1-Year Return 13.58%
This Quarter Return
+3.64%
1 Year Return
-13.58%
3 Year Return
+22.36%
5 Year Return
+42.01%
10 Year Return
AUM
$152M
AUM Growth
+$6.07M
Cap. Flow
+$1.37M
Cap. Flow %
0.9%
Top 10 Hldgs %
34.86%
Holding
377
New
30
Increased
71
Reduced
71
Closed
22

Sector Composition

1 Technology 10.59%
2 Healthcare 7.94%
3 Communication Services 6.6%
4 Consumer Staples 4.09%
5 Financials 3.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GSK icon
276
GSK
GSK
$81.5B
$5K ﹤0.01%
122
NVO icon
277
Novo Nordisk
NVO
$245B
$5K ﹤0.01%
+140
New +$5K
OMF icon
278
OneMain Financial
OMF
$7.31B
$5K ﹤0.01%
+100
New +$5K
RPG icon
279
Invesco S&P 500 Pure Growth ETF
RPG
$1.72B
$5K ﹤0.01%
155
VEA icon
280
Vanguard FTSE Developed Markets ETF
VEA
$171B
$5K ﹤0.01%
+97
New +$5K
ZBH icon
281
Zimmer Biomet
ZBH
$20.9B
$5K ﹤0.01%
31
ETHE
282
Grayscale Ethereum Trust ETF
ETHE
$4.89B
$5K ﹤0.01%
+337
New +$5K
ATVI
283
DELISTED
Activision Blizzard Inc.
ATVI
$5K ﹤0.01%
55
+50
+1,000% +$4.55K
AAL icon
284
American Airlines Group
AAL
$8.63B
$4K ﹤0.01%
150
BDX icon
285
Becton Dickinson
BDX
$55.1B
$4K ﹤0.01%
15
DAL icon
286
Delta Air Lines
DAL
$39.9B
$4K ﹤0.01%
81
-419
-84% -$20.7K
DD icon
287
DuPont de Nemours
DD
$32.6B
$4K ﹤0.01%
46
VWO icon
288
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
$4K ﹤0.01%
+80
New +$4K
CARR icon
289
Carrier Global
CARR
$55.8B
$3K ﹤0.01%
65
CTSH icon
290
Cognizant
CTSH
$35.1B
$3K ﹤0.01%
33
EL icon
291
Estee Lauder
EL
$32.1B
$3K ﹤0.01%
10
FMC icon
292
FMC
FMC
$4.72B
$3K ﹤0.01%
30
RBLX icon
293
Roblox
RBLX
$88.5B
$3K ﹤0.01%
+42
New +$3K
VUG icon
294
Vanguard Growth ETF
VUG
$186B
$3K ﹤0.01%
10
SIXG
295
Defiance Connective Technologies ETF
SIXG
$633M
$3K ﹤0.01%
75
HACK icon
296
Amplify Cybersecurity ETF
HACK
$2.29B
$2K ﹤0.01%
33
HEDJ icon
297
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.79B
$2K ﹤0.01%
+52
New +$2K
JNK icon
298
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
$2K ﹤0.01%
+15
New +$2K
NUE icon
299
Nucor
NUE
$33.8B
$2K ﹤0.01%
20
NVS icon
300
Novartis
NVS
$251B
$2K ﹤0.01%
25